ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system (2021)
Pimentel, Franklin Fernandes; Buzatto, Isabela Panzeri Carlotti; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Peruchi, Karoline P. I.; Andrade, Jurandyr Moreira de ; Tiezzi, Daniel Guimarães
Source: Cancer Research. Conference titles: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, NEOPLASIAS MAMÁRIAS, MENOPAUSA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27. Acesso em: 01 nov. 2024. , 2021
APA
Pimentel, F. F., Buzatto, I. P. C., Rodrigues, T. C. G. F., Borba, J. M. C., Peruchi, K. P. I., Andrade, J. M. de, & Tiezzi, D. G. (2021). Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS9-27
NLM
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Vancouver
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Trabalho de evento-resumo periodico
Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic (2021)
Pimentel, Franklin Fernandes; Borba, Jéssica Maria Camargo; Rodrigues, Tamara Cristina Gomes Ferraz; Peruchi, Karoline P. I.; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Source: Cancer Research. Conference titles: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, TERAPÊUTICA MÉDICA, COVID-19, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30. Acesso em: 01 nov. 2024. , 2021
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS13-30
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Artigo de periodico
IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment (2015)
Benevides, Luciana; Fonseca, Denise Morais da ; Donate, Paula Barbim; Tiezzi, Daniel Guimarães; Carvalho, Daniel D. de; Andrade, Jurandyr Moreira de; Martins, Gislaine Aparecida; Silva, João Santana da
Source: Cancer Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, CARCINOMA DE DUCTOS INFILTRANTE, CITOCINAS, SOBREVIVÊNCIA LIVRE DE DOENÇA, REGULAÇÃO GÊNICA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENEVIDES, Luciana et al. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, v. 75, n. 8, p. 3788-3799, 2015Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-15-0054. Acesso em: 01 nov. 2024.
APA
Benevides, L., Fonseca, D. M. da, Donate, P. B., Tiezzi, D. G., Carvalho, D. D. de, Andrade, J. M. de, et al. (2015). IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Research, 75( 8), 3788-3799. doi:10.1158/0008-5472.CAN-15-0054
NLM
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054
Vancouver
Benevides L, Fonseca DM da, Donate PB, Tiezzi DG, Carvalho DD de, Andrade JM de, Martins GA, Silva JS da. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment [Internet]. Cancer Research. 2015 ; 75( 8): 3788-3799.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1158/0008-5472.CAN-15-0054

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em